Literature DB >> 17014981

Reliability and validity of a computerized neurocognitive test battery, CNS Vital Signs.

C Thomas Gualtieri1, Lynda G Johnson.   

Abstract

CNS Vital Signs (CNSVS) is a computerized neurocognitive test battery that was developed as a routine clinical screening instrument. It is comprised of seven tests: verbal and visual memory, finger tapping, symbol digit coding, the Stroop Test, a test of shifting attention and the continuous performance test. Because CNSVS is a battery of well-known neuropsychological tests, one should expect its psychometric properties to resemble those of the conventional tests upon which it is based. 1069 subjects age 7-90 participated in the normative database for CNSVS. Test-retest reliability (TRT) was evaluated in 99 Ss who took the battery on two separate occasions, separated, on the average, by 62 days; the results were comparable to those achieved by equivalent conventional and computerized tests. Concurrent validity studies in 180 subjects, normals and neuropsychiatric patients, indicate correlations that are comparable to the concurrent validity of similar tests. Discriminant validity is supported by studies of patients with mild cognitive impairment and dementia, post-concussion syndrome and severe traumatic brain injury, ADHD (treated and untreated) and depression (treated and untreated). The tests in CNSVS are also sensitive to malingerers and patients with conversion disorders. The psychometric characteristics of the tests in the CNSVS battery are very similar to the characteristics of the conventional neuropsychological tests upon which they are based. CNSVS is suitable for use as a screening instrument, or as a serial assessment measure. But it is not a substitute for formal neuropsychological testing, it is not diagnostic, and it will have only a limited role in the medical setting, absent the active participation of consulting neuropsychologists.

Entities:  

Mesh:

Year:  2006        PMID: 17014981     DOI: 10.1016/j.acn.2006.05.007

Source DB:  PubMed          Journal:  Arch Clin Neuropsychol        ISSN: 0887-6177            Impact factor:   2.813


  208 in total

Review 1.  Reliability of Computerized Neurocognitive Tests for Concussion Assessment: A Meta-Analysis.

Authors:  James L Farnsworth; Lucas Dargo; Brian G Ragan; Minsoo Kang
Journal:  J Athl Train       Date:  2017-08-03       Impact factor: 2.860

2.  Validity of a computerized version of the symbol digit modalities test in multiple sclerosis.

Authors:  Nadine Akbar; Kimia Honarmand; Nancy Kou; Anthony Feinstein
Journal:  J Neurol       Date:  2010-10-06       Impact factor: 4.849

3.  Cognitive performance in a placebo-controlled pharmacotherapy trial for youth with marijuana dependence.

Authors:  Amanda Roten; Nathaniel L Baker; Kevin M Gray
Journal:  Addict Behav       Date:  2015-01-23       Impact factor: 3.913

4.  Training the Motor Aspects of Pre-driving Skills of Young Adults With and Without Autism Spectrum Disorder.

Authors:  Johnell Brooks; Julie Kellett; Julia Seeanner; Casey Jenkins; Caroline Buchanan; Anne Kinsman; Desmond Kelly; Susan Pierce
Journal:  J Autism Dev Disord       Date:  2016-07

5.  Cognitive remediation for adolescents with 22q11 deletion syndrome (22q11DS): a preliminary study examining effectiveness, feasibility, and fidelity of a hybrid strategy, remote and computer-based intervention.

Authors:  Margaret A Mariano; Kerri Tang; Matthew Kurtz; Wendy R Kates
Journal:  Schizophr Res       Date:  2015-06-01       Impact factor: 4.939

Review 6.  Assessment, management and knowledge of sport-related concussion: systematic review.

Authors:  Doug King; Matt Brughelli; Patria Hume; Conor Gissane
Journal:  Sports Med       Date:  2014-04       Impact factor: 11.136

7.  Advances in designs for Alzheimer's disease clinical trials.

Authors:  Jeffrey Cummings; Heath Gould; Kate Zhong
Journal:  Am J Neurodegener Dis       Date:  2012-11-18

Review 8.  Applications of technology in neuropsychological assessment.

Authors:  Carolyn M Parsey; Maureen Schmitter-Edgecombe
Journal:  Clin Neuropsychol       Date:  2013-09-16       Impact factor: 3.535

9.  Examining the durability of a hybrid, remote and computer-based cognitive remediation intervention for adolescents with 22q11.2 deletion syndrome.

Authors:  Margaret A Mariano; Kerri Tang; Matthew Kurtz; Wendy R Kates
Journal:  Early Interv Psychiatry       Date:  2016-09-15       Impact factor: 2.732

10.  Adults with sickle cell disease may perform cognitive tests as well as controls when processing speed is taken into account: a preliminary case-control study.

Authors:  Regina D Crawford; Charles R Jonassaint
Journal:  J Adv Nurs       Date:  2015-08-20       Impact factor: 3.187

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.